Lecap Asset Management Ltd. raised its position in shares of Doximity, Inc. (NASDAQ:DOCS – Free Report) by 235.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,940 shares of the company’s stock after acquiring an additional 27,341 shares during the quarter. Lecap Asset Management Ltd.’s holdings in Doximity were worth $2,079,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the company. FMR LLC raised its holdings in shares of Doximity by 30.5% during the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the last quarter. State Street Corp increased its holdings in shares of Doximity by 2.5% in the third quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after purchasing an additional 88,922 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Doximity by 19.8% in the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock valued at $124,503,000 after purchasing an additional 472,565 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Doximity by 4.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock valued at $32,808,000 after purchasing an additional 31,966 shares during the last quarter. Finally, Lord Abbett & CO. LLC acquired a new stake in shares of Doximity in the third quarter valued at approximately $29,453,000. Institutional investors and hedge funds own 87.19% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently commented on DOCS shares. Stephens started coverage on Doximity in a report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price target for the company. Needham & Company LLC increased their price target on Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a report on Friday. KeyCorp cut their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th. Leerink Partners upgraded Doximity from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $60.00 to $90.00 in a research report on Friday. Finally, The Goldman Sachs Group started coverage on Doximity in a research report on Friday, November 15th. They issued a “neutral” rating and a $58.00 price objective for the company. Twelve analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $59.12.
Insider Activity at Doximity
In related news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 37.40% of the stock is currently owned by company insiders.
Doximity Stock Up 0.7 %
DOCS opened at $58.58 on Friday. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The business has a fifty day simple moving average of $55.09 and a 200-day simple moving average of $45.31. The firm has a market cap of $10.94 billion, a P/E ratio of 67.33, a P/E/G ratio of 4.68 and a beta of 1.39.
Doximity (NASDAQ:DOCS – Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.24 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). The company had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. Doximity had a net margin of 33.69% and a return on equity of 19.79%. During the same quarter last year, the business posted $0.18 earnings per share. Sell-side analysts expect that Doximity, Inc. will post 0.88 earnings per share for the current year.
Doximity Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
- Five stocks we like better than Doximity
- Stock Dividend Cuts Happen Are You Ready?
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- How to Buy Cheap Stocks Step by Step
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- What is a SEC Filing?
- These are the 3 Stocks Most Likely to Split in 2025
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.